Saturday 6 July 2024

Ewopharma

ewopharma_company
Ewopharma, based in Schaffhausen, Switzerland, seeks partnership opportunities to market pharmaceuticals and consumer health products in Central Eastern Europe.

Ewopharma covers all regulatory and commercial aspects of market access and development.

Latest Ewopharma News & Features

Ewopharma partners with CStone on sugemalimab
28 May 2024
BRIEF—Ewopharma gets rights to Eisai's Lenvima in CEE
26 March 2020
Companies answer call to provide amikacin in Switzerland
29 July 2019
Ewopharma to commercialize Eisai drugs in Central Eastern Europe
23 June 2017


Today's issue

Pharmaceutical
ABPI calls on new UK government to address inequalities in access to medicines
5 July 2024
Biotechnology
Leqvio and Repatha to spearhead lipid-modifying agents market resurgence
5 July 2024
Biotechnology
New FDA approval for Roche’s Vabysmo
5 July 2024
Pharmaceutical
Probe into risk of optic nerve disease from semaglutide
5 July 2024
Biotechnology
Servier deals blow to Pieris as oncology collab comes to end
5 July 2024
Biotechnology
First hemophilia B patients treated with Hemgenix in Europe
5 July 2024
Pharmaceutical
Pharma giants breach UK industry code of practice
5 July 2024




Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze